What Is the Significance of Lysosomal-Mediated Resistance to Imatinib?
The lysosomal sequestration of hydrophobic weak-base anticancer drugs is one proposed mechanism for the reduced availability of these drugs at target sites, resulting in a marked decrease in cytotoxicity and consequent resistance. While this subject is receiving increasing emphasis, it is so far onl...
Main Author: | Petr Mlejnek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/5/709 |
Similar Items
-
The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane
by: Michal Stark, et al.
Published: (2020-04-01) -
Imatinib Mesylate (STI 571) – A New Oral Target Therapy For Chronic Myelogenous Leukemia (CML)
by: Ladislav Chrobák, et al.
Published: (2003-01-01) -
The Potential Role of Lysosomal Sequestration in Sunitinib Resistance of Renal Cell Cancer
by: Kaamar Azijli, et al.
Published: (2016-01-01) -
Management of gastrointestinal stromal tumors: from diagnosis to treatment
by: JF Egger
Published: (2004-03-01) -
Mechanisms of drug resistance in nutrient-depleted colorectal cancer cells: insights into lysosomal and mitochondrial drug sequestration
by: Serra Gülse Köse, et al.
Published: (2024-10-01)